AVDL
Price
$14.62
Change
-$0.25 (-1.68%)
Updated
Aug 28 closing price
Capitalization
1.42B
68 days until earnings call
HLN
Price
$9.69
Change
-$0.02 (-0.21%)
Updated
Aug 28 closing price
Capitalization
43.75B
62 days until earnings call
Interact to see
Advertisement

AVDL vs HLN

Header iconAVDL vs HLN Comparison
Open Charts AVDL vs HLNBanner chart's image
Avadel Pharmaceuticals
Price$14.62
Change-$0.25 (-1.68%)
Volume$1.03M
Capitalization1.42B
Haleon
Price$9.69
Change-$0.02 (-0.21%)
Volume$6.75M
Capitalization43.75B
AVDL vs HLN Comparison Chart in %
Loading...
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVDL vs. HLN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a StrongBuy and HLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AVDL: $14.62 vs. HLN: $9.69)
Brand notoriety: AVDL: Notable vs. HLN: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVDL: 87% vs. HLN: 62%
Market capitalization -- AVDL: $1.42B vs. HLN: $43.75B
AVDL [@Pharmaceuticals: Generic] is valued at $1.42B. HLN’s [@Pharmaceuticals: Generic] market capitalization is $43.75B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 1 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVDL and HLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 5 TA indicator(s) are bullish while HLN’s TA Score has 5 bullish TA indicator(s).

  • AVDL’s TA Score: 5 bullish, 4 bearish.
  • HLN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HLN is a better buy in the short-term than AVDL.

Price Growth

AVDL (@Pharmaceuticals: Generic) experienced а -1.35% price change this week, while HLN (@Pharmaceuticals: Generic) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.61%. For the same industry, the average monthly price growth was +12.19%, and the average quarterly price growth was +85.29%.

Reported Earning Dates

AVDL is expected to report earnings on Nov 05, 2025.

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($43.7B) has a higher market cap than AVDL($1.42B). AVDL YTD gains are higher at: 39.106 vs. HLN (3.358). HLN has higher annual earnings (EBITDA): 2.71B vs. AVDL (7.87M). HLN has more cash in the bank: 676M vs. AVDL (81.5M). AVDL has less debt than HLN: AVDL (2.73M) vs HLN (8.45B). HLN has higher revenues than AVDL: HLN (11B) vs AVDL (221M).
AVDLHLNAVDL / HLN
Capitalization1.42B43.7B3%
EBITDA7.87M2.71B0%
Gain YTD39.1063.3581,165%
P/E RatioN/A21.53-
Revenue221M11B2%
Total Cash81.5M676M12%
Total Debt2.73M8.45B0%
FUNDAMENTALS RATINGS
AVDL: Fundamental Ratings
AVDL
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVDLHLN
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
59%
MACD
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
41%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 9 days ago
57%
Declines
ODDS (%)
Bearish Trend 23 days ago
82%
Bearish Trend 3 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDCVX17.610.08
+0.46%
Janus Henderson International Div C
NBMBX18.78N/A
N/A
Neuberger Berman Mid Cap Growth Adv
TGADX30.79N/A
N/A
Templeton Growth Adv
PMCKX25.34N/A
N/A
Victory Pioneer Mid Cap Value R6
GCEPX9.94N/A
N/A
Goldman Sachs Clean Energy Income P

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-0.21%
HLNCF - HLN
49%
Loosely correlated
+0.10%
TAK - HLN
43%
Loosely correlated
+0.74%
ZTS - HLN
40%
Loosely correlated
-0.37%
ALKS - HLN
30%
Poorly correlated
-1.09%
PRGO - HLN
29%
Poorly correlated
-0.54%
More